Article Versions Notes

Chen D, Niu M, Jiao X, Zhang K, Liang J, Zhang D. Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. 2012; 13(1):1186-1208. https://doi.org/10.3390/ijms13011186

Chen, Dong, Min Niu, Xuelong Jiao, Kejun Zhang, Jun Liang, and Dianliang Zhang. 2012. "Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma" International Journal of Molecular Sciences 13, no. 1: 1186-1208. https://doi.org/10.3390/ijms13011186

Chen, D., Niu, M., Jiao, X., Zhang, K., Liang, J., & Zhang, D. (2012). Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences, 13(1), 1186-1208. https://doi.org/10.3390/ijms13011186